Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Bonner, James A, Prof, Harari, Paul M, Prof, Giralt, Jordi, Prof, Cohen, Roger B, Prof, Jones, Christopher U, MD, Sur, Ranjan K, Prof, Raben, David, Prof, Baselga, Jose, Prof, Spencer, Sharon A, Prof, Zhu, Junming, PhD, Youssoufian, Hagop, MD, Rowinsky, Eric K, MD, Ang, K Kian, Prof
Published in The lancet oncology (2010)
Published in The lancet oncology (2010)
Get full text
Journal Article